Karras Nolan E. 4

4 · MERIT MEDICAL SYSTEMS INC · Filed Jun 20, 2019

Form 4

Period: 2019-06-19

Director

Transactions

Exercise/Conversion
Common Stock, No Par Value
2019-06-19$9.95/sh+6,000$59,700→ 8,000 total
Sale
Common Stock, No Par Value
2019-06-19$60.91/sh−4,000$243,640→ 4,000 total
Exercise/Conversion
Non-qualified stock options (right to buy)
2019-06-19−6,000→ 16,000 total
Exercise: $9.95From: 2014-05-22Exp: 2020-05-22→ Common Stock (6,000 underlying)

Holdings

Non-qualified stock options (right to buy)
Exercise: $18.80From: 2017-05-26Exp: 2023-05-26→ Common Stock (25,000 underlying)
25,000
Non-qualified stock options (right to buy)
Exercise: $50.50From: 2019-06-07Exp: 2025-06-07→ Common Stock (25,000 underlying)
25,000
Non-qualified stock options (right to buy)
Exercise: $52.17From: 2020-05-24Exp: 2026-05-24→ Common Stock (13,750 underlying)
13,750
Common Stock, No Par Value
(indirect: By Trust)
2,000
Non-qualified stock options (right to buy)
Exercise: $20.27From: 2016-05-22Exp: 2022-05-22→ Common Stock (25,000 underlying)
25,000
Non-qualified stock options (right to buy)
Exercise: $34.40From: 2018-05-24Exp: 2024-05-24→ Common Stock (25,000 underlying)
25,000
Common Stock, No Par Value
(indirect: By IRA)
4,000
Non-qualified stock options (right to buy)
Exercise: $13.99From: 2015-06-11Exp: 2021-06-11→ Common Stock (25,000 underlying)
25,000
Non-qualified stock options (right to buy)
Exercise: $52.17From: 2020-05-31Exp: 2026-05-31→ Common Stock (7,500 underlying)
7,500

Footnotes (10)

[F1]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.815 to $60.980, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F10]Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.
[F2]Shares held jointly by the reporting person and his spouse.
[F3]Becomes exercisable in equal annual installments of 20% commencing 05/22/2014.
[F4]Becomes exercisable in equal annual installments of 20% commencing 06/11/2015.
[F5]Becomes exercisable in equal annual installments of 20% commencing 05/22/2016.
[F6]Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.
[F7]Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
[F8]Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
[F9]Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.

Documents

1 file